An open-label phase 2 trial of entospletinib in indolent non-Hodgkin lymphoma and mantle cell lymphoma. [electronic resource]
Producer: 20190917Description: 215-222 p. digitalISSN:- 1365-2141
- Adult
- Aged
- Aged, 80 and over
- Female
- Humans
- Indazoles -- administration & dosage
- Lymphoma, B-Cell, Marginal Zone -- drug therapy
- Lymphoma, Follicular -- drug therapy
- Lymphoma, Mantle-Cell -- drug therapy
- Male
- Middle Aged
- Neoplasm Proteins -- antagonists & inhibitors
- Pyrazines -- administration & dosage
- Syk Kinase -- antagonists & inhibitors
- Waldenstrom Macroglobulinemia -- drug therapy
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.